SP

Shubhrajyoti Panda

Active Director Director DIN 11319241
DIN 11319241 First appointment Sep 2025 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value •••• Premium profile

About Shubhrajyoti Panda

Data last updated:

Shubhrajyoti Panda is a Director at Posian Pharma Private Limited (since 2025). The company operates in Chemicals. Posian Pharma Private Limited reported revenue of ₹30.3 Lakh (FY 2023).

DIN 11319241
Primary Designation Director
Industry Chemicals
First Appointment 27 Sep 2025
Largest company Posian Pharma Private Limited · ₹30.3 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Posian Pharma Private Limited U24232OR2010PTC011689
Director27 Sep 2025₹30.3 Lakh (FY 2023)Active

Board colleagues of Shubhrajyoti Panda

Directorship timeline

Open interactive timeline →
Posian Pharma Private Limited
Premium access

Shareholding and investment profile for Shubhrajyoti Panda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubhrajyoti Panda

Shubhrajyoti Panda currently holds 1 directorship: Posian Pharma Private Limited (Director, since 27 Sep 2025, revenue ₹30.3 Lakh (FY 2023)).

Shubhrajyoti Panda was first appointed on 27 Sep 2025 as Director at Posian Pharma Private Limited.

The current boards of Shubhrajyoti Panda's companies include Nalini Kanta Panda (Posian Pharma Private Limited), Samir Kumar Paikaray (Posian Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available